Research Topics
Species | B L EvattSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
The natural evolution of haemophilia care: developing and sustaining comprehensive care globallyB L Evatt
World Federation of Hemophilia, Atlanta, GA 30345, USA
Haemophilia 12:13-21. 2006....- The tragic history of AIDS in the hemophilia population, 1982-1984B L Evatt
World Federation of Hemophilia, and Division of Hematology, Centers for Disease Control, Atlanta, GA, USA
J Thromb Haemost 4:2295-301. 2006 - Demographics of hemophilia in developing countriesBruce L Evatt
Division of Hereditary Blood Disorders, Centers for Disease Control, Atlanta, Georgia 30333, USA
Semin Thromb Hemost 31:489-94. 2005..This information will most certainly assist in guiding the future of hemophilia care in these countries with emerging economies... - Infectious disease in the blood supply and the public health responseBruce Evatt
Hematologic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30345, USA
Semin Hematol 43:S4-9. 2006..The ongoing safety of blood therapies and the blood supply will also depend on continued vigilance and research. Finally, the hemophilia community must be allowed to play an active and educated role in their own care... - Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrateJ M Soucie
Division of AIDS, STD, and TB Laboratory Research, and the Respiratory and Enterovirus Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30033, USA
Transfusion 40:708-11. 2000..This report describes an investigation to determine the extent of product contamination and to evaluate past recipients of porcine clotting factor (Hyate:C, Speywood Biopharm) for evidence of PPV infection... - Prions and haemophilia: assessment of riskB L Evatt
Hematologic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Haemophilia 4:628-33. 1998.... - The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African AmericansW C Hooper
Hematologic Disease Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Center for Disease Control and Prevention, Atlanta, GA 30333, USA
Chest 116:880-6. 1999..Because these two genes may interact physiologically, the third objective was to determine if there was a relationship between the polymorphisms with respect to MI and VTE... - Emerging and receding risks of therapeutic regimens for haemophiliaA Farrugia
Office of Devices, Blood and Tissues, Australian Therapeutic Goods Administration, Australia
Haemophilia 10:47-54. 2004..Despite the advent of new and promising treatments for haemophilia, heathcare providers must be alert to new risks posed by them... - Observations from Global Survey 2001: an emerging database for progressB L Evatt
Hematologic Diseases Branch, Division of AIDS, STD and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Haemophilia 8:153-6. 2002 - Effects of HIV infection on age and cause of death for persons with hemophilia A in the United StatesT L Chorba
Division of Immunologic, Oncologic, and Hematologic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Atlanta, Georgia, USA
Am J Hematol 66:229-40. 2001.... - Risk factors for infection with HBV and HCV in a largecohort of hemophiliac malesJ M Soucie
Hematologic Diseases Branch, Division of AIDS, Sexually Transmitted Diseases, and Tuberculosis Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Transfusion 41:338-43. 2001..Before the implementation of donor screening and the development of effective virus-inactivation procedures, persons with hemophilia (PWHs) were at risk of infection with HBV and HCV transmitted through clotting factor concentrates... - Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of transmission to recipients with hemophiliaW Heneine
HIV and Retrovirology Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
J Infect Dis 183:648-52. 2001..None of the samples was positive. Our data document that PERV particles are a common contaminant of Hyate:C products and suggest that the risk of PERV transmission from these percutaneous exposures is very low... - Hepatitis A virus infections associated with clotting factor concentrate in the United StatesJ M Soucie
Division of AIDS, STD, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Transfusion 38:573-9. 1998..An investigation was conducted to find additional cases and determine the source of infection... - Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic menD N Lawrence
Division of Host Factors, Centers for Disease Control, Atlanta, GA
Am J Hematol 30:68-76. 1989..Four were diagnosed in latter 1987. The median age at diagnosis was 4.5 months. Four had died. None of their mothers is as yet diagnosed... - Comprehensive care for haemophilia around the worldB L Evatt
Division of Hereditary Blood Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, USA
Haemophilia 10:9-13. 2004..In this paper we present perspectives from different areas of the world on how to adopt, adapt and achieve economically appropriate models of comprehensive care... - Haemophilia 2002: emerging risks of treatmentB L Evatt
Hematologic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Haemophilia 8:221-9. 2002.... - Tumor necrosis factor-alpha downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell lineW C Hooper
Hematologic Diseases Branch, Centers for Disease Control and Prevention, Altanta, GA 30333
Blood 84:483-9. 1994..We suggest that TNF-alpha downregulation of protein S may be a mechanism for localized procoagulant activity and thrombosis recently reported in some AIDS patients with associated protein S deficiency... - Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American womenC H Miller
Hematologic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Am J Hematol 67:125-9. 2001..The finding of increased vWF:Ag not accompanied by increased vWF:RCof has implications for understanding the structure-function relationships of vWF. Published 2001 Wiley-Liss, Inc... - HIV Infection and thrombocytopeniaBruce L Evatt
Curr Hematol Rep 4:149-53. 2005..Therapy should be directed at reducing the load of the HIV virus of the patient supplemented by other therapies chosen depending on the specific underlying cause... - Prevalence and risk factors for heart disease among males with hemophiliaRoshni Kulkarni
Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan, USA
Am J Hematol 79:36-42. 2005..In summary, persons with hemophilia have unique risk factors such as infusion of factor concentrates and infection with HIV that may predispose them to heart disease as their life expectancy increases... - Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitationJ Michael Soucie
Division of Hereditary Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30303, USA
Transfusion 44:1179-85. 2004..Also, data collected on joints were used to assess relations between B19 serostatus and joint range-of-motion (ROM) limitation... - Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophiliaMarilyn J Manco-Johnson
University of Colorado and Health Sciences Center, Denver, USA
N Engl J Med 357:535-44. 2007..Effective ways to prevent arthropathy in severe hemophilia are unknown...